Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Autoimmune Gastrointestinal Dysmotility
Interventions
DIAGNOSTIC_TEST

Blood sample collection

Patients with autoimmune gastrointestinal dysmotility will provide 20 mL of blood to isolate serum, plasma and peripheral blood mononuclear cells for whole exome sequence. Antibodies to be isolated are: Antineuronal nuclear antibody type 1,Collapsing response-mediator family immunoglobulin G, Ganglionic Acetylcholine Receptor Antibody, Muscle Acetylcholine Receptor Antibody, Striational, Voltage-gated calcium channel, N- type, Voltage-gated calcium channel, P/Q- type, Voltage-gated potassium channel, Glutamic Acid Decarboxylase 65, Gastric parietal cell, Thyroperoxidase, Thyroglobulin

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER